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Abstract
During the development of the topographic map from vertebrate retina to superior colliculus (SC), EphA receptors are
expressed in a gradient along the nasotemporal retinal axis. Their ligands, ephrin-As, are expressed in a gradient along the
rostrocaudal axis of the SC. Countergradients of ephrin-As in the retina and EphAs in the SC are also expressed. Disruption
of any of these gradients leads to mapping errors. Gierer’s (1981) model, which uses well-matched pairs of gradients and
countergradients to establish the mapping, can account for the formation of wild type maps, but not the double maps
found in EphA knock-in experiments. I show that these maps can be explained by models, such as Gierer’s (1983), which
have gradients and no countergradients, together with a powerful compensatory mechanism that helps to distribute
connections evenly over the target region. However, this type of model cannot explain mapping errors found when the
countergradients are knocked out partially. I examine the relative importance of countergradients as against compensatory
mechanisms by generalising Gierer’s (1983) model so that the strength of compensation is adjustable. Either matching
gradients and countergradients alone or poorly matching gradients and countergradients together with a strong
compensatory mechanism are sufficient to establish an ordered mapping. With a weaker compensatory mechanism,
gradients without countergradients lead to a poorer map, but the addition of countergradients improves the mapping. This
model produces the double maps in simulated EphA knock-in experiments and a map consistent with the Math5 knock-out
phenotype. Simulations of a set of phenotypes from the literature substantiate the finding that countergradients and
compensation can be traded off against each other to give similar maps. I conclude that a successful model of retinotopy
should contain countergradients and some form of compensation mechanism, but not in the strong form put forward by
Gierer.
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Introduction
During late prenatal and early postnatal neural development in
vertebrates the axons from retinal ganglion cells (RGCs) grow and
are pruned so as to form a topographic mapping from the retina to
its target regions. To explain how regenerating fibres in goldfish
innervate the appropriate part of tectum [1], Sperry proposed that
the establishment of the map depends on retinal and target cells
expressing varying levels of biochemical labels that allow growth
cones to identify their correct targets by finding cells with a
matching or complementary label [2]. Broadly consistent with this
chemoaffinity hypothesis, during the period in which the map is
formed, EphA and EphB receptors are expressed in gradients
along orthogonal axes of the retina and their ligands, ephrin-As
and ephrin-Bs, are expressed along orthogonal axes of the superior
colliculus (SC) or optic tectum, and Eph-ephrin signalling has been
shown to have a role in guidance [3].
Much recent work has focused on one dimension of the
mapping, from the retinal nasotemporal axis to the rostrocaudal
axis of the SC. In mouse and chick, EphA receptors are
expressed in a low-to-high gradient along the nasotemporal axis
of the retina, and their ligands, ephrin-As, in a low-to-high
gradient along the rostrocaudal axis of the SC [3–7]. Via forward
signalling, activation of axonal EphA receptors by ephrin-A
expressed in the tectum leads to axon repulsion [5]. There is
also expression of ephrin-As along the nasotemporal axis of the
retina, but as a countergradient to the retinal EphAs, i.e. a
gradient in the opposing (high-to-low) direction [7–9]. Corre-
spondingly, there is a countergradient (high-to-low) of EphA
expressed along the rostrocaudal axis of the SC, in opposition
to the ephrin-A gradient. The activation of axonal ephrin-A by
EphA in the SC, called reverse signalling [10,11], also inhibits
axon growth [12]. Genetic manipulations of EphAs or ephrin-
As cause disruptions to the topographic map [12–22].
Gierer’s models [23–25] indicated that matched gradient and
countergradient pairs with inhibitory interactions could establish
topographic maps. This model and elaborated versions of it [26]
are consistent with and provide an explanation for the existence of
countergradients [12,22]. However, the model contains the strong
assumption that gradients and countergradients are closely
matched, presumably by genetic mechanisms. It has been argued
[27] that matched gradients and countergradients alone cannot
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account for perturbations such as the double maps produced in
mice in which extra EphA is expressed in RGCs at random using a
knock-in strategy [15,16]. In contrast, these maps are predicted by
models containing gradients with fibre-target forward signalling
and adaptive mechanisms such as competition [28,29] or marker
induction [30] but which do not include countergradients with
reverse signalling.
Nevertheless, given that genetic manipulations of counter-
gradients cause mapping errors [12,22], it is important to
understand their role in models of map development. The main
aim of this paper is to investigate how countergradients and
various forms of compensatory mechanism might interact. For this
I use a modified version of Gierer’s model of 1983 which contains
both countergradients and a compensatory mechanism. This 30-
year old model has been chosen because, while it is not as
comprehensive as more recent models, its simple formulation
allows the relative influence of countergradients and adaptive
mechanisms to be assayed. Features absent from Gierer’s model
but present in others include activity [29,31–34], cis- fibre-fibre
interactions [35], fasciculation and defasiculation effects [36] and
induction of collicular gradients [30]. One other advantage of
Gierer’s model is that it does not require strong assumptions to be
made about the tuning of the size and interaction strength of
forward and reverse gradients implicit in a number of models
[26,33,34,36]. A secondary aim of this paper, motivated by the
recommendation that existing models should be tested against new
data [37], is to determine whether the Gierer model can account
for the recent data derived from EphA3 knock-in [15,16] and
Math5 knock-out [32] phenotypes.
Results
Gradients and Countergradients without Compensation
do not Ensure Topographic Map Formation
The model, depicted in Fig. 1 and detailed in the Models section
and Table 1, has a generalised version of the mathematical
structure of the 1983 Gierer model [24], but the gradients are
interpreted as being EphAs and ephrin-As, which had not been
identified in 1983. I make the assumption, justified in the
Discussion, that the mapping from the two-dimensional retinal
surface to the two-dimensional surface of the superior colliculus
(SC) can be simplified by supposing that the mapping from the
nasotemporal axis to the rostrocaudal axis occurs independently
from the mapping from the dorsoventral axis to the mediolateral
axis. I focus on the nasotemporal to rostrocaudal mapping and the
associated signalling system of EphAs and ephrin-As because it is
better understood than the EphB and ephrin-B signalling
associated with the dorsoventral to mediolateral mapping.
Along the nasotemporal axis of the retina (Fig. 1A) there is a
low-to-high gradient of EphA and a countergradient of ephrin-A
running from high-to-low. Along the rostrocaudal axis of the SC
(Fig. 1B) there is a low-to-high gradient of ephrin-A and a high-
to-low countergradient of EphA. A temporal retinal ganglion
cell (RGC) axon (labelled (1) in Fig. 1C) therefore bears more
EphA than ephrin-A, whereas the converse is true of a nasal
axon (labelled (2) in Fig. 1C). Via the forward signalling
pathway, the EphA on each axon interacts with the ephrin-A
on each SC cell to produce a signal that inhibits branching and
that is proportional to the product of the densities of EphA on
the axon and the ephrin-A on the SC cell. Since the amount of
ephrin-A varies throughout the SC, so does the inhibitory
signal. The branching inhibition for the reverse signalling
pathway is taken to be the product of the densities of ephrin-A
on the RGC axon and EphA on the SC cell.
The branching inhibition signals produced by the forward
and reverse pathways are summed to produce the net branching
inhibition signals for RGC axons (1) and (2) seen in Fig. 1D.
The most favourable location for axon (1) to branch is at the
rostral end of the SC, where the branching inhibition is lowest.
This is the topographically ’’correct’’ position for this axon. The
most favourable location for axon (2) to branch is just over
halfway along the rostrocaudal axis; this is not the correct
position for this nasal axon, which should connect to the caudal
end of the SC.
Figure 1. Overview of model. A, B Gradients and countergradients
of EphA and ephrin-A in the retina and SC. Collectively the retinal EphA
and collicular ephrin-A make up the forward system referred to as
gradients and are indicated in green; the retinal ephrin-A and collicular
EphA make up the reverse system referred to as countergradients and
are indicated in orange. C A temporal RGC (1, blue) and a nasal (2, red)
RGC and their expected preferred locations of arborisation in the SC
shown schematically as side branches tipped with growth cones. D The
branching inhibition due to the sum of gradient and countergradient
signalling experienced by the temporal (blue) and nasal (red) axon
along the rostrocaudal axis of the SC. Minima are indicated by
arrowheads. E The branching inhibition due to density compensation
experienced by both axons along the rostrocaudal axis of the SC as the
system is approaching its final configuration. F The total branching
inhibition for each RGC; this is the sum of the corresponding curve in D
and the curve in E. G The discrete implementation. A terminal (red filled
synapse) is picked at random and moved in the direction of lower total
branching inhibition for that axon (indicated by heights of red bars).
doi:10.1371/journal.pone.0067096.g001
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This shows that in a model in which there are only fibre-target
interactions, the gradient and countergradient (or forward and
reverse signalling) systems do not necessarily ensure formation of a
topographic map. In theory, the parameters of the gradients and
countergradients could be matched so that a perfect topographic
map is formed (see Models section). However it would seem to be
hard to achieve this precise matching biologically and, as can be
verified using the simulation method presented later, mismatches
can result in the entire colliculus not being covered and/or
bunching of connections at one end (data not shown). Further-
more, even if the gradients could be arranged to produce the
desired mapping the system would not be robust to surgical
manipulations or changes in the gradients, whereas considerable
robustness to perturbations have been observed in a variety of
species [14–16,38,39]. A recent model suggests that Eph/ephrin
forward and reverse fibre-fibre interactions between RGCs could
compensate for mismatched gradients [35]. However, it is not
clear if this result depends on a precise matching of the parameters
of the fibre-fibre interactions (see Discussion).
Strong Compensation with Gradients but no
Countergradients Produces a Topographic Map
To account for expansion and contraction experiments [38,39],
Gierer [24] proposed adding a mechanism, which he called
’’regulation’’, to the model described so far. The use of the term
’’regulation’’ is unfortunate as it has a specific meaning in
developmental biology, so for clarity I use the term ’’compensa-
tion’’. The idea entails axonal growth cones inhibiting each other’s
growth by releasing an inhibitory substance that builds up over
time. The greater the density of growth cones in a small region of
the SC, the harder it is for growth cones to make connections
there. For example, in Fig. 1C there are no growth cones in the
caudal SC, and a greater density of growth cones at the rostral
end, thus leading to a larger density compensation factor there
(Fig. 1E). This density compensation factor is then added to the
branching inhibition factor (Fig. 1D) to give the total branching
inhibition (Fig. 1F). It can be seen that the minima of the total
branching inhibition for the temporal RGC (1) and the nasal RGC
(2) are approximately topographically appropriate.
Thus the density compensation factor depends on the locations
of the terminals, and the locations of the terminals depend on the
density compensation factor. To understand the effect of this
feedback loop, a discrete simulation, based on Gierer’s, is used
(Fig. 1G). At the start of the simulation, 240 RGCs, each with 16
terminals, are allocated to 240 SC cells randomly. (For clarity, only
two RGCs, each with four terminals, and eight SC cells are
displayed in Fig. 1G.) At each time step, a terminal is chosen at
random (red filled synapse of nasal RGC). If the total branching
inhibition (indicated by red filled bars) in either neighbouring SC
cell is lower, the terminal moves to the neighbour with the lowest
branching inhibition (indicated by arrow). The numbers of
terminals in each SC location are updated and the compensation
factor at each location is then increased in proportion to the
number of terminals there. In simulations described later, the
compensation factor decays over time, leading to a weaker form of
compensation.
Given the widespread view that the Gierer model requires
gradients and countergradients, it is worth considering, as Gierer
did [24], the effect of strong compensation with gradients but no
countergradients (Fig. 2). Because only the forward signalling
gradient system is present (Fig. 2A,B), all axons are less inhibited at
the rostral end of the SC, and throughout the SC an axon is more
inhibited the more temporal its origin (Fig. 2C). In Fig. 2D the
mapping from a sample of the 240 axons onto the SC is shown at
three points in time. Initially (t~0) there is a random mapping
from axons to the SC. The density at each SC location
(corresponding panel in Fig. 2E) has a mean value of 16 (the
number of terminals per SC cell), but there are fluctuations,
meaning that some locations receive more branches than others.
The density compensation factor is set initially to zero throughout
the SC (Fig. 2F). The branching inhibition for each axon is shown
in Fig. 2G, with the colours of the three curves indicating a
temporal axon (blue), a nasal axon (red) and an axon midway
along the NT axis (purple).
Later on (t~50) the mapping and the density curve (Fig. 2D,E)
show that terminals are more densely packed in the rostral half of
the SC. This is reflected in the density compensation factor
(Fig. 2F), which is also beginning to build up at the rostral end,
causing small shifts in the locations of the minima of the total
branching inhibition curves (Fig. 2G). By t~1000 an ordered
mapping has emerged, and the density of terminals in the SC is
uniform, with fluctuations. This is because the density compen-
sation curve has become more pronounced and shifted the
locations of the minima of the total branching inhibition curves to
their correct locations.
In summary, it can be seen that a mapping does develop,
despite the fact that initially all axons are attracted towards the
rostral edge of the SC. This happens because the slope of the
branching inhibition experienced by nasal axons (red axons in
Fig. 2), which bear the least EphA, is smaller throughout the SC
than the slope of the branching inhibition of temporal axons (in
blue), which bear more EphA. The increase in the compensation
factor that occurs at the overpopulated end of the SC is therefore
relatively more important to the nasal axons than to the temporal
ones, and is sufficient to displace the minima of their branching
inhibition curves to the caudal SC. In the final, ordered, mapping,
the temporal (blue) axons experience more repulsion throughout
the SC than do the nasal (red) ones, but nevertheless the minima
are arranged in an ordered fashion.
The complete absence of the reverse signalling molecules shown
in Fig. 2A,B has not been obtained experimentally - it would
require conditional knock-out of all the ephrin-A subtypes from
the retina and all the EphA subtypes from the SC. However, the
same simulation results are obtained if the reverse system
molecules are abolished in either the retina or the colliculus since
the reverse component will be removed from the branching
inhibition (Equation 1 in the Models section). By symmetry,
perfect maps would also result from knocking out either the retinal
or SC forward signalling molecules. There is no mutant in which
either the forward or reverse pathway has been eliminated
completely.




The table shows the expressions for the concentrations [EphA](u) and
[ephrinA(u) of EphA and ephrin-A at a distance u along the nasotemporal axis
of the retina and the concentrations [ephrinA](x) and [EphA(x) of ephrin-A
and EphA at a distance x along rostrocaudal axis of the SC. The temporal pole
of the retina lies at u~0 and the nasal pole at u~1. In the SC x~0 is the rostral
pole and x~1 is the caudal pole. The heights of gradients in the retina and SC
are denoted by R and S respectively, with a subscript ’’E’’ or ’’e’’ to denote
whether it is an Eph or ephrin. These subscripts are also applied to the decay or
rise constants of retinal and SC gradients, denoted r and s respectively.
doi:10.1371/journal.pone.0067096.t001
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The mutant whose gradients resemble removal of counter-
gradients in one structure most closely is the unconditional ephrin-
A5 knock-out [14]. As ephrin-A5 is the only graded ephrin-A
present in the eye, there is no countergradient of ephrin-A5 in the
eye, although there is a constant level of the residual ephrin-A3
and ephrin-A2. There is still a gradient of ephrin-A2 in the
colliculus, albeit a weak one with a peak towards the caudal end.
In the EphA7 knock-out, the countergradient of EphA in the SC is
weakened though not entirely removed [12]. In both these
mutants there are mapping errors with ectopic termination zones.
This suggests that the model’s mapping is better than expected and
that this might be due to the effect of the strong form of
compensation.
Weak Compensation with Gradients but no
Countergradients Produces a Distorted Mapping
In Gierer’s model [24] the concentration of the compensatory
substance can only ever increase. This idealised form of
compensation has an infinitely long memory of the density of
connections in the target region, making it strong, but also
biologically implausible. I therefore modified Gierer’s model so
that the compensatory substance decays in proportion to its
concentration (see Equation 2 in the Models section), giving a
weaker form of compensation.
Fig. 3 shows the effect of replacing the strong compensation
employed in the previous simulation with gradients and no
countergradients (Fig. 2) with this weaker form of compensation.
The mapping starts to develop (t~50) in a similar fashion as when
there is strong compensation. However, in the final mapping
(t~1000) terminals are shifted rostrally from their ideal positions,
and the density of connections at the caudal end of the SC is much
lower than at the rostral end (Fig. 3E). The compensation factor
(Fig. 3F) has reached a steady state, and its range is slightly less
than when there is strong compensation (Fig. 2), meaning it has
less power to spread out the terminals appropriately. This
demonstrates that if the compensation is weak, it is not able to
overcome the rostral bias conferred by having only gradients and
not countergradients.
The shifted projections are reminiscent of the shifted projections
observed in unconditional ephrin-A knock-outs [14,19], albeit in
the opposite direction. Also, in the model there is only one
termination zone from each retinal location, in contrast with the
experimental ephrin-A knock outs, in which multiple termination
zones are found in the SC from some retinal DiI injections. Had
the countergradient system (retinal ephrin-As and SC EphAs) been
present and the gradient system (retinal EphAs and SC ephrin-As)
been knocked out, the situation would have been similar except for
the shifts in the terminals being in the caudal direction.
Figure 2. Gradients with strong compensation and no counter-
gradients. A, B The gradients (green) of EphA in the retina and ephrin-
A in the SC and the countergradients (orange, set to zero) of retinal
ephrin-A and EphA in the SC. C The branching inhibition throughout
the SC for axons from all locations along the nasotemporal axis of the
retina. Lighter shading indicates more inhibition. D–G The time
evolution of the mapping. Each column indicates the mapping at one
instant. D The locations of terminals from the retina (y-axis) to the SC (x-
axis). The retinal origin of the axons is indicated by the continuous
shading from nasal (red) to temporal (blue). E The number of terminals
r connected to each SC cell. F The level of the branching inhibition c
due to density compensation throughout the SC. G The value of the
total branching inhibition p for three axons, whose retinal origin is
indicated by the colour of the filled circles on the y-axis of D. Gradient
parameters (see Table 1 for explanation): RE~Se~1, rE~se~1.
Countergradient parameters: Re~SE~0. Decay parameter g~0 and
e~0:005.
doi:10.1371/journal.pone.0067096.g002
Figure 3. Weak compensation with gradients but no counter-
gradients. The gradients and countergradients are the same as in Fig.
2 but there is now weak instead of strong compensation. Meaning of
panels as in Fig. 2. In the final mapping (D, t~1000) terminals are
displaced rostrally from the ideal mapping, indicated by the solid line.
Gradient parameters: RE~Se~1, rE~se~1. Countergradient parame-
ters: Re~SE~0. Decay parameter g~0:0768 and e~0:005.
doi:10.1371/journal.pone.0067096.g003
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Addition of Weak Countergradients to Gradients with
Weak Compensation Improves the Mapping
In the presence of strong compensation, the addition of
countergradients does nothing to improve the mapping (simula-
tions not shown), since gradients and strong compensation already
give rise to a perfect mapping (Fig. 2). However, with weak
compensation and gradients without countergradients (Fig. 3) the
mapping is shifted. To investigate if countergradients could have a
function when there is weak compensation, I added weak
countergradients, half the height of the gradients (Fig. 4A,B), a
combination that without compensation would be expected to
produce a shifted mapping. In the final mapping (t~1000) there
are still rostral shifts, though less pronounced than without any
countergradients (Fig. 3). The countergradient has acted in concert
with the compensation mechanism to produce a mapping that is
more towards the ideal map. The combination of gradients,
countergradients and compensation in this simulation gives the
closest approximation to the wild-type phenotype of the simula-
tions presented so far: the mapping is reasonable (Fig. 4), and it is
distorted by knocking-out the countergradients (Fig. 3).
Gradients, Countergradients and Weak Compensation
can Produce ki-ki and Math5 Phenotypes
A good model of retinotopy should be able to reproduce, at least
qualitatively, the phenotypes produced by experimental genetic
manipulations when analogous manipulations are applied to the
model. I therefore tested whether a model with gradients, weak
countergradients and weak compensation can reproduce the
EphA3 knock-in [15–17] and Math5 knock-out [32] phenotypes.
In EphA3 knock-in mice, a constant amount of EphA is
knocked into around 40% of RGCs randomly throughout the
retina [15–17], leading to a phenotype in which there are double
maps, one each from the wild-type and knocked-in RGC
populations. I simulated this by ’’knocking-in’’ some EphA in to
every second axon, as shown in Fig. 5. The parameters of the
retinal EphA gradients and the amount of EphA3 knocked in were
taken from in-situ hybridisation experiments [16]. The extra
EphA3 gives two sets of EphA gradients in the retina, and a double
map reminiscent of that found experimentally [15,16] develops.
Double maps also form when strong compensation is present
(simulations not shown). These results indicate that weak
compensation can confer the kind of flexibility needed to redirect
terminals to positions to which they would not project normally.
The Math5 knock-out [32] has approximately 5% of the
number of RGCs of a wild type, roughly evenly distributed across
the retina. This leads to the density of termination zones being
higher in rostral SC than caudal SC. I examined whether a model
with gradients, weak countergradients and weak compensation
could reproduce this behaviour by removing 95% of the RGCs in
the model. The resulting ’’phenotype’’, with the same set of
mismatched gradients used in Fig. 4, is shown in Fig. 6. The map
covers the rostral third of the SC (Fig. 6G, t~1000), a coverage
that is actually considerably lower than the biological phenotype.
However, this does demonstrate how the model works: with fewer
axons there is less pressure on terminals to move away from the
favoured locations at the rostral end of the SC.
As well as the homozygous knock-in of EphA3 (as modelled in
Fig. 5), there are heterozygous knock-in mice, in which half as
much EphA3 is knocked-in [15]. These knock-in mice have been
bred with heterozygous and homozygous EphA4 knock-out mice
[16], in which EphA4, normally expressed uniformly along the
nasotemporal axis of the retina, is either absent or expressed at half
its usual strength. There are thus six combinations of combined
knock-in and knock-out mutants, each of which has had the map
along the nasotemporal axis measured anatomically [15,16].
Along with the wild type and the Math5 knock-out, this gives a set
of 8 maps against which to test the model. In each map apart from
the Math5 knock-out, the retinal EphA gradients and the amount
of EphA3 knocked in have been measured using in-situ
hybridisation experiments [16]; I assume that gradients in the
Math5 knock-out are the same as in wild types. Fig. 7A–H shows
the gradients (equations for which are in Table 2) and resulting
maps for each mutant. The countergradients (not shown) are the
same as in Fig. 5 and the compensation is stronger. The fit for
most maps is good, as indicated by the goodness-of-fit measure x2
(see Models section for definition). The two mutants with obviously
bad fits are the heterozygous knock-ins with heterozygous or
homozygous knock-out of EphA4 (Fig. 7E,G). Here the axons with
extra EphA3 are not shifted as rostrally as they are in the
experiments.
In three of the mutants (EphA3ki=zEphA4z=z,
EphA3ki=zEphA4z={, and EphA3ki=zEphA4{={) experimental
DiI injections show that there are two maps, though towards the
rostral end of the SC the two maps appear to merge, or ’’collapse’’
[16]. The corresponding simulations (Fig. 7C,E,G) show that the
distributions of terminals from neighbouring temporal EphA3z
and EphA3{ RGCs do overlap along the rostrocaudal axis; in a
simulated DiI injection experiment, in which the terminals of a
number of RGCs within a radius of the injection site are labelled,
this might give the appearance of a single termination zone, as
seen in the experiments. However, this is not the strict ’’collapse’’
which occurs in some models that include the effect of spatially
Figure 4. Addition of weak countergradients to gradients with
weak compensation. The gradients and level of compensation is the
same as in Fig. 3 but weak countergradients (orange) have been added.
Meaning of panels as in Fig. 2. In the final mapping (D, t~1000) the
rostral displacements from the ideal mapping are smaller than in Fig. 3.
Gradient parameters: RE~Se~1, rE~se~1. Countergradient parame-
ters: Re~SE~0:5, re~sE~1. Decay parameter g~0:0768 and
e~0:005.
doi:10.1371/journal.pone.0067096.g004
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correlated activity in the retina and an implicit synaptic plasticity
mechanism [29,36]; in these models the mean locations of
branches from neighbouring EphA3z and EphA3{ RGCs are
indistinguishable at the temporal end of the map. This strict
collapse will not occur in the same way in the generalised Gierer
model due to the lack of activity in the model.
The simulations earlier in the paper have suggested a hypothesis
that how well gradients and countergradients are matched can be
traded off against the strength of compensation in order to
produce good wild type maps. In order to explore whether this
holds for a range of mutants, I varied both the strength of
compensation and the size of the retinal ephrin-A counter-
gradients. For each combination I recorded a total goodness-of-fit
parameter and plotted it in the 2D parameter space formed by the
compensation strength and the countergradient size (not shown). I
found that for any particular size of countergradients, there was an
optimal strength of compensation; the larger the countergradients,
the weaker the compensation required for the best set of maps.
Fig. 7I–P shows the simulation results for countergradients 4 times
as strong as those in Fig. 7A–H and with compensation 10 times as
weak, as measured by the decay factor. The overall fit is 17%
worse (see Models for definition of goodness-of-fit measure), but
for each phenotype the fit is still reasonably good apart from in the
heterozygous EphA3 knock-ins with heterozygous or homozygous
knock-out of EphA4 (Fig. 7M,O).
Discussion
What is the Role of Countergradients?
Gierer’s 1983 model [24] was devised to account for the
compression [38] and expansion [39,40] of maps in goldfish. I
have applied the model to investigate the relative functional
importance of countergradients and compensation mechanisms in
mice. Provided there is a sufficiently powerful compensation
mechanism, countergradients are not needed for an ideal
retinocollicular map to develop. This is contrary to the experi-
mental results obtained when part of the countergradient system
(EphAs in the SC) is knocked out [12] : mapping deficits occur.
When both gradients and countergradients are reduced by
increasing the amounts of ephrin-As knocked out, mapping
deficits also occur and get more severe [14,19,21]. Thus the
perfect mapping obtained in the model with no countergradients
and strong compensation suggests that there is not strong
compensation in the biological system. However, when a more
realistic form of weak compensation is present, addition of
countergradients does improve the mapping, suggesting that
countergradients, along with a limited form of compensation or
other adaptive mechanism, are required for the wild type map to
develop.
I have shown that when the model with weak compensation is
given the gradients which are present in homozygous EphA3
knock-in genotypes [15,16] along with weak countergradients, it is
able to reproduce a double map that resembles the phenotype.
Double maps can also result from simulations with no counter-
Figure 5. EphA homozygous knock-in simulations. Meaning of
panels as in Fig. 2. Experimentally measured retinal EphA gradients (A,
green dotted lines) are used. The upper gradient is found in EphA3z
RGCs, in which EphA3 has been knocked in and the lower gradient is
from the EphA3{ RGCs which have no EphA3 (see Table 2,
EphA3ki=zEphA4z=z for parameters). In the simulations the extra
EphA knocked into alternating RGCs leads to the RGCs bearing more
EphA experiencing greater branching inhibition (G) and there being
two maps (D, t~1000), the rostral-most map being from the EphA3z
RGCs. The experimental maps are indicated by the black points in D,
t~1000 and a nonparametric regression fit to the data is shown with a
solid line; for clarity, the standard error in the mean of the fit is not
shown. The goodness-of-fit x2 between the experimental and simulated
data is also indicated in grey (see Models section for explanation). SC
gradient parameters are as in previous figures: Se~0:5, se~1.
Countergradient parameters: Re~SE~0:3, re~sE~1. Decay parameter
g~0:0768 and e~0:005.
doi:10.1371/journal.pone.0067096.g005
Figure 6. Math5 knock-out simulations. Meaning of panels as in
Fig. 2. There are 5% of the number of RGCs in all the preceding
simulations and all other parameters are identical to Fig. 4. A mapping
that does not cover the entire SC develops (D, t~1000), in contrast to
the mapping shown in Fig. 4D.
doi:10.1371/journal.pone.0067096.g006
Importance of Countergradients for Retinotopy
PLOS ONE | www.plosone.org 6 June 2013 | Volume 8 | Issue 6 | e67096
gradients. However, even if the base gradients and counter-
gradients are matched, some degree of compensation is required to
remap the axons with extra EphA knocked in. In a simulated
Math5 knock-out, in which a large fraction of RGCs are absent,
with unmatched gradients and countergradients the retinal map
can cover a fraction of the SC, rather than whole SC when the full
complement of RGCs are present. This is actually a more extreme
phenotype than is observed along the rostrocaudal axis experi-
mentally [32], but demonstrates the effect of fewer axon terminals
releasing less inhibitory substance, allowing axons to settle towards
the end of the SC favoured by chemospecific cues.
The wild type simulations in which compensation and counter-
gradients were varied lead to the hypothesis that the ratio of
countergradient to gradient strength and the strength of compen-
sation can be traded off against each other: the stronger the
countergradients are relative to gradients, the weaker the
compensation needs to be to obtain wild type maps, and vice-
versa. To test this more rigorously, I ran the model with various
levels of countergradients and compensation on a set of retinal
EphA gradients for wild type, Math5 knock-out and combinations
of hetero- and homozygous EphA3 knock-in and EphA4 knock-
out, measuring the goodness-of-fit between the simulated maps
and maps measured in experiments [15,16]. The fits were not
good for all phenotypes, but the hypothesis was confirmed:
stronger countergradients meant that weaker compensation was
needed for the best set of maps.
Within the Gierer framework the conclusion that gradients,
weak countergradients and weak compensation is sufficient to
explain a range of data from mouse does not necessarily extend to
other species. In goldfish the terminals of regenerating nerves from
a temporal hemiretina first occupy rostral tectum and then, over a
period of months, expand to fit the tectum [39]. Conversely,
regenerating nasal axons occupy caudal tectum initially [1] and
gradual spreading of these fibres is also reported [41]. These
results imply that the gradients and countergradients in fish are
matched. However, this reasoning is within the framework of fixed
gradients, and theories involving respecification of the gradients
[30,39,42,43] would not require matching of gradients. Likewise,
in zebrafish the results from experiments in which the effect of
competition has been removed [44] suggest that fairly well-
matched gradients and countergradients would be needed.
However, this experiment was undertaken at one developmental
stage; and in zebrafish the area of the tectum increases over 100-
fold whilst innervated by retinal axons [45], raising the question of
how stable the gradients actually are.
Is Gierer’s Compensation Mechanism Supported by Data?
The assumption behind Gierer’s strong compensation mecha-
nism - that molecular mechanisms of synapse formation and
destruction will tend to maintain equal numbers of synapses onto
target cells - is reasonable. However, strong compensation can be
ruled out, since the build-up of inhibitory substance in proportion
to the density of terminals over time without any decay is
biologically implausible. It also leads to a perfect map in the case of
gradients without countergradients (Fig. 2). A weaker and
biologically plausible form of compensation, with decay over
time, produces distorted maps in wild types with mismatched
gradients and countergradients, but cannot product the ectopic
projections observed experimentally in ephrin-A and EphA knock-
outs.
The molecular identity of neither density compensation nor
competition is known, though the BDNF-TrkB pathway has been
put forward as a candidate to implement competition [16].
Alternatively, if a SC neuron releases BDNF when it has fewer
than a target number of inputs, this could be viewed as a form of
density compensation, albeit with an attractive rather than
inhibitory cue. Another mechanism that may have a similar effect
to density compensation is homoeostatic plasticity [46], whereby
the total synaptic strength onto a postsynaptic neuron is regulated.
Do the Model Simplifications and Data Limitations
Matter?
Do any of the simplifications inherent in the model and
limitations of the experimental data invalidate the conclusions
drawn above? A potentially critical simplification is the reduction
of the geometry of the retina and the SC from two-dimensional
manifolds to one-dimensional lines. The justification for this is
twofold. (1) The EphA/ephrin-A family are aligned approximately
with the nasotemporal and rostrocaudal axes of the retina and the
SC respectively, whereas the EphB/ephrin-B family are aligned
approximately with the dorsoventral and mediolateral axes. (2)
Simulations have been carried out which demonstrate that the
powerful spreading action of the compensation mechanism also
occurs in 2D, including a case when there are gradients and no
countergradients along each axis [47].
A second important simplification is that activity and activity-
dependent plasticity are not considered in the model. Clearly
activity plays a role in the development of the mapping from the
retina to the SC, though it is thought to be more important for
refining projections that have been structured roughly by other
mechanisms [27]. The mapping obtained in the model without
countergradients and with weak compensation (Fig. 4) is still more
ordered than the experimental mappings, in that there are none of
the ectopic projections present in most knock-out phenotypes
[12,14,19]. It is possible that the addition of an activity mechanism
might lead to the production of ectopics [48].
Modelling of the gradients is limited by the data available. I
have made educated guesses about the profile of retinal ephrin-A
and SC EphA and ephrin-A gradients since they have not been
measured quantitatively, as have the retinal EphA gradients [16].
This does not affect the qualitative conclusion that counter-
gradients and compensation can coexist and complement each
other. However, it may affect the goodness-of-fit found in Fig. 7,
since changes in the steepness of the countergradients will lead to a
compression or expansion of the branching inhibition profile (see
Equation 5 in Models section). Furthermore, it is probable that the
various members of the EphA and ephrin-A families bind to each
other with different affinities, but lack of reliable quantitative
information on the expression profiles means that it is not
worthwhile modelling all the EphAs and ephrin-As separately.
Table 2. Retinal EphA gradients for knock-in simulations.
Genotype EphA3- EphA3z







The EphA retinal gradients used in the various genotypes modelled in Figs. 5
and 7 in RGCs that do not have EphA3 knocked in (EphA3{) or that do have
EphA3 knocked in (EphA3{).
doi:10.1371/journal.pone.0067096.t002
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Comparison with Other Models
There are two main classes of chemoaffinity models of
retinocollicular mapping [49]. In Type I models
[23,25,26,33,36] each retinal cell has a high affinity for a small
group of collicular cells and less affinity for all others. In Type II
models all cells have the highest affinity for one end of the SC. To
produce a map, Type II models require some additional
mechanism such as competition [32,49], activity [29,48,50] or
marker induction [30,43]. The marker induction model differs
from all the other models in that the gradients in the target region
are not fixed, flexibility being achieved by ingrowing fibres
inducing these gradients.
The model presented here can be set up either as a Type I
model, with matched gradients and countergradients, or as a Type
II model, with gradients and no countergradients. The interme-
diate case, with mismatched gradients and countergradients, is a
Type I model in the sense that each retinal cell has a collicular cell
of maximum affinity, but the collicular cell with which it has
maximum affinity is not the topographically ’’correct’’ cell.
Although the model presented here has fixed gradients, it could
be that the density compensation is implemented by modification
of EphA and ephrin-A gradients, in which case it would be a form
of marker induction [30].
A recent proposal [34] does not fit the strict definition of either
Type I or Type II models. Here each retinal cell has an almost
equal affinity for a relatively large group of collicular cells (of the
order of 50% of one axis of the SC) and virtually no affinity for
other cells. Initially, branches are formed in the regions permitted
by these affinities, and then an activity-dependent process refines
the connections. There are two problems with this proposal. First,
there is no mechanism to relate the relatively gentle gradients of
Ephs and ephrins into the box-shaped affinity functions proposed.
Figure 7. Two sets of mutant simulations. A Wild type gradients (left) and location of RGC terminals in SC (right) at end point (t~1000) of
simulation with decay parameter g~0:01 and same level of countergradients as in Fig. 5. The experimental map is indicated by original data (points)
and nonparametric regression fit (solid line); for clarity, the standard error in the mean of the fit is not shown. The goodness-of-fit x2 between the
experimental and simulated data is also indicated in grey (see Models section for explanation). B–G The six combinations of EphA3 knock-in and
EphA4 knock-out in same format as (A). H The Math5 knock-out, with 5% of the number of RGCs as the wild type (A). I–P. Corresponding simulations
to A–H, but with retinal countergradients four times as strong and weaker compensation (due to the tenfold larger decay parameter g~0:1).
Parameter e~0:05 in all simulations.
doi:10.1371/journal.pone.0067096.g007
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These affinity functions have to be constructed independently of
gradients, meaning that there is no principle apparent in the
affinity functions used to model the EphA3 knock-ins. Second, the
model does require an affinity function that gives a rough wild-
type map to work; in this sense the model is closer to the Type I
models.
The recent model of Triplett et al. [32] has a number of
similarities with the generalised Gierer model. In the Gierer model
the number of terminals per axons is fixed, whereas in the Triplett
et al. model, it is encouraged to lie around a particular value. In
the Triplett et al. model a ’’competition’’ term penalises each SC
cell in proportion to the square of the number of terminals on it,
whereas in the generalised Gierer formulation, the penalty (due to
the inhibitory substance) is directly proportional to a moving
average of the number of terminals on the SC cell. In the limit of a
very small averaging time window, the models will be identical
apart from the non-linearity in the Triplett et al. model and how
the adaptive mechanisms and fixed molecular mechanisms are
scaled relative to each other.
A recent model [35] appears have the flexibility inherent in
Type II models with some sort of compensatory mechanism. Here
the interactions between Ephs and ephrins on the ingrowing
retinal axons (fibre-fibre interactions) can help to spread out the
mapping in the face of mismatched gradients. However, it appears
that for this to happen, the relative strengths of the forward and
reverse signalling pathways have to be tightly controlled.
Challenges in Understanding Mechanisms of Retinotopy
While much experimental data has been collected in recent
years, existing models have not been tested rigorously against the
data [37]. A necessary condition to have explained the develop-
ment of retinotopy in mouse is to have created a model that, with
suitable changes to gradient parameters, can account for the
knock-in phenotypes and the many knock-out phenotypes in the
literature [7,12–16,18–22]. This requires an adequate character-
isation of the experimental data and a measure of goodness of fit
between a model and an experimental phenotype. This is
particularly challenging for the knock-out phenotypes because
the anatomical mapping data is not comprehensive in the sense
that in any one animal only a few injections of tracers are possible,
so the data obtained in any one animal is only a very small section
of the mapping. The variability of the arborisations of RGCs from
the same retinal locations between ephrin-A knock-out individuals
will probably confound attempts to construct a composite map
across individuals, as has been done in the knock-in phenotypes
[15,16]. Functional mapping techniques [21] overcome the
problem of obtaining an entire map, but methods are needed to
detect and quantify ectopic termination zones using these
methods.
A successful model will be sensitive - but not too sensitive - to
the relative strengths of multiple mechanisms. At present, no one
model with the same set of parameters satisfies this condition. I
hope this paper has illustrated the challenges implicit in finding
such a model.
Models
The mathematical details of the model, a generalised version of
Gierer’s (1983) model, are presented here; for justifications of its
elements see the Results and Discussion.
Gradients and Countergradients
There is a concentration [EphA](u) of EphA and a concentra-
tion [ephrinA(u) of ephrin-A at point u along the nasotemporal
axis of the retina; u~0 is the temporal pole and u~1 is the nasal
pole (Fig. 1A). Along the rostrocaudal axis of the SC there are
concentrations [ephrinA](x) and [EphA(x) of ephrin-A and
EphA respectively; x~0 is the rostral pole and x~1 is the caudal
pole (Fig. 1B). The shapes of gradients are described by
exponential curves and the height and slope of each curve is a
free parameter, making eight parameters in total (Table 1).
Branching Inhibition due to Molecular Gradient
Signalling
For a terminal belonging to an axon originating at a point u
along the nasotemporal axis, the branching inhibition g(x,u) due
to forward and reverse EphA to ephrin-A binding it experiences at
point x along the rostrocaudal axis of the SC (Fig. 1D) is:
g(x, u)~½EphA (u) ½ephrinA (x)
z½ephrinA (u) ½EphA (x)
ð1Þ
There are other expressions that could be used for g, for
example ones involving receptor or ligand saturation [23,29].
Branching Inhibition Due to Density Compensation
The branching inhibition due to density compensation c(x,t)
experienced by all terminals at a time t at a point x in the SC
(Fig. 1E) depends on the density r(x,t) of connections in that
region of the SC:
Lc
Lt
~er(x, t){gc(x, t) ð2Þ
where e specifies how quickly c changes in response to the density
and g parametrises the rate of decay. In simulations with strong
compensation g~0. When there is weak compensation g is a
positive number and a steady state could arise, in which
c(x,t)~(e=g)r(x,t).
Total Branching Inhibition
The contributions to branching inhibition from molecular
gradient signalling and density compensation are summed to give
the total branching inhibition p:
p(x, u, t)~g(x, u, t)zc(x, t) ð3Þ
The dynamics of the system, as described below, mean that an
axon originating from location u will tend to move towards a
location x that minimises its total branching inhibition p(x,u,t).
Discrete Implementation
So far, for ease of notation and algebraic manipulations to be
presented later, the model has been formulated as though the SC
were a continuous medium. It is of course a collection of discrete
neurons and the mapping is from individual RGCs i to SC cells j.
The continuous representation can be translated into a discrete
one by denoting the positions of RGC i as ui and the position of
SC cell j as xj ; the quantities p(xj ,ui) and g(xj ,ui,t) can be
abbreviated pji and gji(t).
At the start of the simulation the 16 terminals of each RGC are
allocated to SC cells randomly. At each time step, a terminal is
chosen at random; suppose that the terminal is on SC cell j. If the
branching inhibition in either neighbouring SC cell is lower, the
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terminal moves to the neighbour with the lowest branching
inhibition. After moving, the values of the density rj and rj{1 or
rjz1 are updated. The compensation factor c is then updated for
all locations j:
cj(tzDt)~cj(t)z(erj(t){gcj(t))Dt ð4Þ
where Dt is set to the reciprocal of the total number of terminals
(i.e. the product of the number of axons and the number of
terminals per axon). This scaling should mean that the mapping
progresses at the same apparent rate in systems of differing sizes.
The update scheme that Gierer [24] used is not clear from his
paper, but the endpoints of the results I obtain are the same as his;
a more detailed discussion is available elsewhere [51]. All
simulations and analysis were carried out in R [52] and the code
is available in the supporting information (Dataset S1).
Matching Gradients
The end result of a successful mapping mechanism should be a
map in which axons along the nasotemporal axis of the retina are
mapped onto the rostrocaudal axis of the SC. With our definition
of u and x, this means that the destination of an axon originating
from u should be x~u. For any particular form of gradients of
retinal and SC Ephs and ephrins, we can compute the expected
mapping from the retina to the SC. The assumption of
exponential gradients [23] allows for simple mapping formulae
in terms of eight parameters, the heights (RE,Se,Re,SE) and decay
or rise constants (rE,se,re,sE) of each of the four exponentials
(Table 1). Given that each axon tries to find the position of
minimum branching inhibition, the optimal position of an axon
originating from location u can be computed by substituting the
expressions for the EphA and ephrin-A concentrations into
Equation 1 and finding the value of x for which the derivative





From this formula it can be seen that a perfect mapping x~u
can be formed by setting all the heights to the same value and all
the decay and rise constants to the same value. There are also an
infinite number of parameter settings in which the mapping is
shifted and expanded or contracted.
Goodness-of-fit to Experimental Data
The wild type and EphA3 knock-in experimental data sets
comprise pairs (ui,xi) of nasotemporal sites and the location of the
corresponding termination zone in the SC. The Math5 knock-out
data set is strictly a profile of the cumulative intensity of dye in the
SC following a whole-eye injection, and I have interpreted this as
forming a map. Nonparametric regression with a local-linear
estimator and Kullback-Leiber cross-validation as implemented in
the R np package [53] was used to estimate for distance along the
nasotemporal axis u the distance of the injection along the
rostrocaudal axis mx(u). The nonparametric regression also gave
an estimate of the error in the mean sx(u). From the simulation
results, the weighted mean location xi of the terminals from RGC i




j wji where wji is the
number of terminals from axon i on SC cell j. The goodness-of-fit










where M is the number of RGCs. For mutants in which there
were double maps, x2 was computed separately for the EphA3z
and EphA3{ maps, and the resulting x2 values were averaged. For
the entire set of mutants (Fig. 7) the x2 values were averaged to
give an overall value.
Supporting Information
Dataset S1 Complete source code for the simulations.
This allows the simulations underlying Figs. 2, 3, 4, 5, 6, 7 in this
paper to be run and the results plotted.
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